TheraNym Biologics’ Rs 1,200-cr manufacturing facility inaugurated in TelanganaIllustrative image – not actual.

Industries Minister D Sridhar Babu inaugurated the biologics manufacturing facility of Theranyme Biologics, a wholly-owned subsidiary of Aurobindo Pharma, at Borpatla village in Sangareddy district of Telangana on 03 June, 2026.

Developed with an investment of Rs 1,200 crore, the facility represents a major addition to Telangana’s growing biotechnology and pharmaceutical ecosystem. Global healthcare company MSD has joined as the anchor customer, providing a strong foundation for the facility’s commercial operations and future growth. The advanced manufacturing unit is designed to produce biologics and critical medicines used in the treatment of cancer and other serious diseases. Products manufactured at the facility will cater to both domestic and international markets, including the United States. Equipped with modern infrastructure and built to meet international regulatory standards, the plant is expected to strengthen India’s position as a global hub for biopharmaceutical manufacturing.

The project also marks Aurobindo Pharma’s strategic entry into the biologics contract manufacturing segment, expanding its presence beyond traditional pharmaceutical products. In addition to supporting healthcare innovation and expanding access to advanced therapies, the facility is expected to create employment opportunities for more than 1,500 local youth.

← All latest storiesBack to top →